Translational Data Inform a Scalable, Noninvasive Test Designed to Identify Treatment-Eligible Patients and Enable Longitudinal Assessment as MASH Therapies Expand Prometheus has been at the forefront of noninvasive liver fibrosis assessment for more than ...

ArianeGroup has successfully carried out the first ignition campaign of the reusable Prometheus® engine on the reusable Themis rocket core stage demonstrator – a key step in providing Europe with the essential technological building blocks for future ...

The Supreme Court unanimously tossed out medical patent claims for Prometheus Laboratories on Tuesday for a test that could help doctors set drug doses for autoimmune diseases like Crohn's disease, a decision that could affect the burgeoning field of ...

PredictrPK IFX is now available for both the induction and maintenance phases of infliximab (IFX) therapy for inflammatory bowel disease (IBD) patients PredictrPK IFX addresses the unmet need of personalized early IFX optimization to support therapeutic ...

PredictrPK ® ADA addresses the unmet need for individualized optimization of adalimumab (ADA) therapy in support of sustained clinical remission and drug persistence. SAN DIEGO, CA / ACCESSWIRE / July 27, 2023 / Prometheus Laboratories Inc. ("Prometheus ...

Translational Data Inform a Scalable, Noninvasive Test Designed to Identify Treatment-Eligible Patients and Enable Longitudinal Assessment as MASH Therapies Expand SAN DIEGO, CA / ACCESS Newswire / May 3, 2026 / Prometheus Laboratories Inc. ("Prometheus ...